Gene Delivery Technologies Market Growth To $8.46 Billion By 2030: What’s Driving The Expansion?

Gene Delivery Technologies Market Report

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Gene Delivery Technologies Market Size, Value And Growth Trajectory Through 2030

The gene delivery technologies market size has experienced rapid growth in recent years. This market is anticipated to expand from $4.29 billion in 2025 to $4.92 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 14.7%. The growth observed in the historic period can be attributed to several factors, including the increase in gene therapy research, the development of viral vectors, academic research funding, the utilization of electroporation techniques, and various vaccine development programs.

The gene delivery technologies market size is anticipated to experience substantial expansion in the coming years. This market is projected to reach $8.46 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.5%. During the projected period, several factors will drive this growth, including the broadening of gene therapy pipelines, advancements in delivery vectors, the need for more secure delivery techniques, the increase in cell therapy uses, and heightened clinical trial engagements. Key trends expected during this forecast span encompass the escalating deployment of both viral and non-viral delivery systems, greater integration into gene and cell therapy, the evolution of lipid nanoparticle technologies, an intensified emphasis on precise gene delivery, and improvements in physical gene transfer techniques.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=40236416&type=smp&name=Gene%20Delivery%20Technologies%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Gene Delivery Technologies Market Opportunity Drivers: What’s Unlocking New Revenue Potential?

The future expansion of the gene delivery technologies market is anticipated to be fueled by the growing prevalence of cell and gene therapies. These therapies are defined as medical interventions designed to treat or mitigate illnesses through modifications to the genetic and cellular composition of a patient’s body. This rise in cell and gene therapies is primarily propelled by innovations in gene editing technologies, which are instrumental in their development and market introduction. Illustrating this trend, IQVIA, a US-based firm specializing in advanced analytics, technology solutions, and contract research services, indicated in March 2025 that new CAR T trial starts totaled 199 in 2024, while gene therapy trial starts reached 130; these numbers represented increases of 54% and 65%, respectively. Consequently, the expansion of cell and gene therapies is a key driver for the gene delivery technologies market.

Gene Delivery Technologies Market Breakdown By Product Type And Application

The gene delivery technologies market covered in this report is segmented –

1) By Mode: Biological, Chemical, Physical

2) By Method: Ex Vivo, In Vivo, In Vitro

3) By Application: Gene Therapy, Cell Therapy, Vaccines, Research

Subsegments:

1) By Biological: Viral Vectors, Bacterial Vectors, Lipid Nanoparticles

2) By Chemical: Cationic Lipids, Polymers, Chemical Transfection Agents

3) By Physical: Electroporation, Microinjection, Gene Gun, Sonoporation

Gene Delivery Technologies Market Innovation Trends: What Developments Are Reshaping The Industry?

Major companies in gene delivery technologies are focused on developing advanced products, such as ProteoAnalyzer, to gain a competitive edge. The ProteoAnalyzer is an advanced automated system developed by Agilent Technologies for protein analysis, specifically utilizing parallel capillary electrophoresis (CE) technology. For instance, in July 2024, Agilent Technologies Inc., a US-based life sciences company, launched the ProteoAnalyzer system. This innovative platform is designed for automated parallel capillary electrophoresis (CE), enabling rapid, high-resolution protein analysis with minimal sample consumption. This capability is particularly beneficial for researchers working with complex protein mixtures in pharmaceuticals, biopharma, and bioengineered food ingredients, facilitating faster discoveries and advancements in translational research. The system allows for detailed examination of protein mixtures, which is crucial for developing therapeutic proteins.

Gene Delivery Technologies Market Company Landscape And Competitive Strategy

Major companies operating in the gene delivery technologies market are Thermo Fisher Scientific Inc., QIAGEN NV, Horizon Discovery Group Co, OriGene Technologies Inc., Oxford Biomedica Solutions LLC, SignaGen Laboratories LLC, Vectalys SAS, Takara Bio Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, Promega Corporation, Catalent Inc., Pfizer Inc., Becton Dickinson and Company, Novartis AG, Intellia Therapeutics Inc., Editas Medicine Inc., CRISPR Therapeutics AG, Spark Therapeutics Inc., Bluebird Bio Inc., Sarepta Therapeutics Inc., Beam Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Moderna Inc., BioNTech SE, Translate Bio Inc., CureVac N.V., Lonza Group AG

View The Full Gene Delivery Technologies Market Report:

https://thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Gene Delivery Technologies Market Top Region By Revenue And Market Share

North America was the largest region in the gene delivery technologies market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global gene delivery technologies market report during the forecast period. The regions covered in the gene delivery technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model